ConductScience.org, home

Paper36944461

CATERPILLAR-study protocol: an assessor-blinded randomised controlled trial comparing taurolidine-citrate-heparin to heparin-only lock solutions for the prevention of central line-associated bloodstream infections in paediatric oncology patients.

van den Bosch CH and 8 others. BMJ Open, 2023. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. CATERPILLAR-study protocol: an assessor-blinded randomised controlled trial comparing taurolidine-citrate-heparin to heparin-only lock solutions for the prevention of central line-associated bloodstream infections in paediatric oncology patients. Papers, record 36944461. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36944461

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CATERPILLAR-study protocol: an assessor-blinded randomised controlled trial comparing taurolidine-citrate-heparin to heparin-only lock solutions for the prevention of central line-associated bloodstream infections in paediatric oncology patients.
PubMed
Journal
BMJ Open
PubMed
Year
2023
PubMed
Publication types
Clinical Trial Protocol, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
1.45
iCite
Revised in PubMed
2026-01-27
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1van den Bosch CHCeder Hildegardhttps://orcid.org/0000-0003-0612-578X
2Loeffen YYvette
3van der Steeg AFWAlida F W
4van der Bruggen JTJan-Tom T
5Frakking FNJFlorine N J
6Fiocco MMarta
7van de Ven CPCornelis P
8Wijnen MHWAMarc H W A
9van de Wetering MDMarianne D

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Central Venous CathetersMajor topic
Catheter-Related InfectionsMajor topic
SepsisMajor topic
NeoplasmsMajor topic
Child
Humans
Heparin
Citric Acid
Quality of Life
Citrates
Randomized Controlled Trials as Topic
Taurine
Thiadiazines

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT05740150Central Line-associated Bloodstream Infection Prevention Using TauroLock-Hep100 in Pediatric Oncology Patients.Derived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18664397Exact estimates for a rate ratio.Epidemiology1996https://conductscience.org/library/papers/8664397PubMed
234767871The efficacy of taurolidine containing lock solutions for the prevention of central-venous-catheter-related bloodstream infections: a systematic review and meta-analysis.J Hosp Infect2022https://conductscience.org/library/papers/34767871PubMed
331145505
Taurolidine-citrate lock solution for the prevention of central line-associated bloodstream infection in paediatric haematology-oncology and gastrointestinal failure patients with high baseline central-line associated bloodstream infection rates.
J Paediatr Child Health2020https://conductscience.org/library/papers/31145505PubMed
420126631Taurolidine antiadhesive properties on interaction with E. coli; its transformation in biological environment and interaction with bacteria cell wall.PLoS One2010https://conductscience.org/library/papers/20126631PubMed
526459655Complications of Central Venous Access Devices: A Systematic Review.Pediatrics2015https://conductscience.org/library/papers/26459655PubMed
618664278Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients.BMC Infect Dis2008https://conductscience.org/library/papers/18664278PubMed
730415957Incidence, severity and outcome of central line related complications in pediatric oncology patients; A single center study.J Pediatr Surg2019https://conductscience.org/library/papers/30415957PubMed
824861410Microbiocidal effects of various taurolidine containing catheter lock solutions.Clin Nutr2015https://conductscience.org/library/papers/24861410PubMed
924841014Complications of total implantable access ports and efficacy of Taurolidine-citrate lock solution against catheter-related infections.Afr J Paediatr Surg2014https://conductscience.org/library/papers/24841014PubMed
1022342714Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.J Hosp Infect2012https://conductscience.org/library/papers/22342714PubMed
1127390716Is Taurolidine-citrate an effective and cost-effective hemodialysis catheter lock solution? A systematic review and cost- effectiveness analysis.Med J Islam Repub Iran2016https://conductscience.org/library/papers/27390716PubMed
1223417891Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin.Pediatr Blood Cancer2013https://conductscience.org/library/papers/23417891PubMed
1323267744Absence of microbial adaptation to taurolidine in patients on home parenteral nutrition who develop catheter related bloodstream infections and use taurolidine locks.Clin Nutr2013https://conductscience.org/library/papers/23267744PubMed
141742385An efficient program for computing conditional maximum likelihood estimates and exact confidence limits for a common odds ratio.Epidemiology1991https://conductscience.org/library/papers/1742385PubMed
1527516141Evidence-based criteria for the choice and the clinical use of the most appropriate lock solutions for central venous catheters (excluding dialysis catheters): a GAVeCeLT consensus.J Vasc Access2016https://conductscience.org/library/papers/27516141PubMed
1617031868Tutorial in biostatistics: competing risks and multi-state models.Stat Med2007https://conductscience.org/library/papers/17031868PubMed
1723799867Antibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancer.Cochrane Database Syst Rev2013https://conductscience.org/library/papers/23799867PubMed
183298185Reduced adherence of micro-organisms to human mucosal epithelial cells following treatment with Taurolin, a novel antimicrobial agent.J Appl Bacteriol1987https://conductscience.org/library/papers/3298185PubMed
1930204661Taurolidine-Citrate Line Locks Prevent Recurrent Central Line-Associated Bloodstream Infection in Pediatric Patients.Pediatr Infect Dis J2019https://conductscience.org/library/papers/30204661PubMed

Download CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
41254792Impact of TauroLock™-HEP500 versus unfractionated heparin for prevention of catheter complications in children with malignancy: a prospective, randomized, controlled study.Eur J Med Res2025https://conductscience.org/library/papers/41254792PubMed
40005772Antimicrobial Lock Therapy in Clinical Practice: A Scoping Review.Microorganisms2025https://conductscience.org/library/papers/40005772PubMed
40001933Biofilm Resilience: Molecular Mechanisms Driving Antibiotic Resistance in Clinical Contexts.Biology (Basel)2025https://conductscience.org/library/papers/40001933PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
LIPC3990PubTator's text mininghttps://conductscience.org/library/genes/3990

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36944461

GET https://conductscience.org/api/papers/v1/36944461/authors